Fellowship · Phoenix, AZ
Sponsored by Barrow Neurological Institute at St Joseph's Hospital and Medical Center
Improving clinical trial outcomes in amyotrophic lateral sclerosis.
Nature reviews. Neurology · 2021 · 225 citations · Jeremy Shefner
Skeletal muscle in amyotrophic lateral sclerosis.
Brain : a journal of neurology · 2023 · 85 citations · Jeremy Shefner
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial.
The Lancet. Neurology · 2021 · 153 citations · Shafeeq Ladha
Diagnostic Utility of Gold Coast Criteria in Amyotrophic Lateral Sclerosis.
Annals of neurology · 2021 · 117 citations · Jeremy Shefner
Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
Brain : a journal of neurology · 2022 · 101 citations · Jeremy Shefner
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis.
Muscle & nerve · 2021 · 141 citations · Shafeeq Ladha, Jeremy Shefner
Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
JAMA neurology · 2021 · 118 citations · Shafeeq Ladha, Jeremy Shefner
Serious Neurologic Adverse Events in Tofersen Clinical Trials for Amyotrophic Lateral Sclerosis.
Muscle & nerve · 2025 · 26 citations · Shafeeq Ladha